首页 > 市场调查报告书 > 医疗设备

药物递输设备抛弃式

北美预充式註射器市场预测至 2030 年 - 区域分析 - 按类型、材料、设计、应用和配销通路

市场调查报告书

商品编码

1494471

北美预充式註射器市场预测至 2030 年 - 区域分析 - 按类型、材料、设计、应用和配销通路

North America Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type, Material, Design, Application, and Distribution Channel

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 96 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美预灌封注射器市值29.9269亿美元，预计2030年将达到67.8362亿美元；预计2022年至2030年复合年增长率为10.8%。

慢性病盛行率的增加推动了北美预充式註射器市场

人口老化的加剧以及社会行为和生活方式的变化导致了一些常见的长期健康状况。根据世界卫生组织 (WHO) 的预测，到 2026 年底，慢性生活方式疾病的盛行率预计将增加 57%。随着都市化进程的不断加快，人们更倾向于久坐的生活方式，进而导致类风湿性关节炎、糖尿病等疾病的发生。糖尿病是21世纪全球主要健康问题之一。根据国际糖尿病联盟（IDF）的数据，2019年北美糖尿病患者人数约为4600万，预计到2045年将达到6200万。

其他慢性病，如克隆氏症、多发性硬化症和心血管疾病，则需要频繁给药以进行疾病管理和治疗。根据世界卫生组织的数据，心血管疾病是死亡的主要原因——每年有近 1,790 万人因心血管疾病死亡。它已成为全球大量患者群体注射给药的新标准。此外，这些预充式註射器只需很少的培训即可供大量患者使用，并且不需要医疗保健专业人员的持续帮助，因此预充式註射器主要在专业医疗保健环境以及家庭医疗保健环境中采用，从而推动了预充式註射器的发展市场成长。

北美预充式註射器市场概况

北美预充式註射器市场分为美国、加拿大和墨西哥。该地区预充式註射器市场的成长主要是由于该地区自註射注射器的采用增加以及用于治疗慢性疾病的家庭医疗保健的激增。

根据糖尿病研究所的数据，2022 年美国糖尿病患者人数约为 3,730 万人（占人口的 11.3%）。此外，美国每年诊断出约 140 万个糖尿病病例。根据美国疾病管制与预防中心的数据，2020 年，约 8,800 万成年人患有糖尿病前期，占美国成年人口的 34.5%。据耶鲁大学研究人员称，到 2022 年，美国约有 3,000 万人患有糖尿病，其中约 700 万人需要每日註射胰岛素。

美国对不孕症治疗的需求不断增加。据 CDC 称，到 2022 年，约 22% 的已婚夫妇（其中女性年龄超过 30 岁）在怀第一个孩子方面存在问题。为了克服不孕问题，市面上可以透过预充式註射器进行各种治疗。 2023 年7 月，费森尤斯·卡比(Fresenius Kabi) 推出了醋酸加尼瑞克注射液(Ganirelix Acetate Injection)，这是一种仿製生育药物，采用250 mcg0.5 ml 预装注射器包装，作为公司在女性健康领域扩张的一部分。因此，糖尿病和其他疾病的盛行率不断上升，以及产品推出的激增，预计将推动美国预充式註射器市场的成长。

北美预充式註射器市场收入及 2030 年预测（百万美元）

北美预充式註射器市场细分

北美预充式註射器市场根据类型、材料、设计、应用、配销通路和国家进行细分。

根据类型，北美预灌封注射器市场分为一次性预灌封注射器和可重复使用预灌封注射器。 2022 年，一次性预灌封注射器细分市场将占据更大的北美预灌封注射器市场。

根据材料，北美预灌封注射器市场分为玻璃预灌封注射器和塑胶预灌封注射器。 2022 年，玻璃预灌封注射器细分市场在北美预灌封注射器市场中占有较大份额。

根据设计，北美预灌封注射器市场分为单间和多室。 2022 年，单室细分市场在北美预充式註射器市场中占据更大份额。

从应用来看，北美预灌封注射器市场细分为癌症、糖尿病、自体免疫疾病、传染病等。到 2022 年，其他细分市场将占据北美预充式註射器最大份额。

依配销通路，北美预充式註射器市场分为医院药局、零售药局和线上通路。 2022 年，医院药局部门占据北美预灌封注射器市场最大份额。

依国家划分，北美预灌封注射器市场分为美国、加拿大和墨西哥。 2022年，美国在北美预充式註射器市场占据主导地位。

B Braun SE、山东威高集团医用聚合物有限公司、Gerresheimer AG、Schott AG、Nipro Corp、Becton Dickinson and Co、Baxter International Inc、Terumo Corp 和 Ypsomed Holding AG 是北美预充式註射器领域的一些领先公司市场注射器领域的一些领先公司市场注射器。

The growing aging population and changes in social behavior and lifestyle contribute to some of the common long-term health conditions. As per the World Health Organization (WHO), the prevalence of chronic lifestyle diseases is expected to increase by 57% by the end of 2026. The emerging markets will be hit hardest, as a population explosion is expected in developing countries. With the increasing urbanization, people are more inclined toward a sedentary lifestyle, which results in rheumatoid arthritis, diabetes, and others. Diabetes is one of the major global health issues of the 21st century. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was about 46 million in 2019 and is projected to reach 62 million by 2045. The increase in disease prevalence is approximated to be 35% during the projection period.

Other chronic conditions such as Crohn's disease, multiple sclerosis, and cardiovascular disorders require frequent drug administration for disease management and treatment. As per the WHO, cardiovascular disorders are the leading cause of death-nearly 17.9 million deaths are reported every year due to cardiovascular disorders. It has become a new standard for injectable drug delivery among large patient populations globally. Moreover, these prefilled syringes can be used by a large patient population with minimal training and do not require constant assistance from healthcare professionals, owing to which prefilled syringes are adopted largely in professional healthcare environments as well as home healthcare settings, thereby driving the prefilled syringes market growth.

North America Prefilled Syringe Market Overview

The North America prefilled syringes market is segmented into the US, Canada, and Mexico. The growth of the prefilled syringes market in the region is mainly due to the increased adoption of self-injecting parenteral devices and a surge in home healthcare to treat chronic diseases in the region.

According to the Diabetes Research Institute, the number of people with diabetes in the US was ~37.3 million (11.3% of the population) in 2022. Nearly 28.7 million people in the US were diagnosed with diabetes, and approximately 8.6 million people have undiagnosed diabetes. Further, ~1.4 million diabetes cases are diagnosed each year in the US. According to the Centers for Disease Control and Prevention, in 2020, ~88 million adults had prediabetes, which is 34.5% of the US adult population. According to Yale researchers, in 2022, ~30 million people in the US have diabetes, and about 7 million require daily insulin.

There is an increase in the demand for infertility treatment in the US. According to the CDC, in 2022, ~22% married couples, with women aged above 30 years, have problems in conceiving their first child. To overcome with infertility issues, various treatments are available in the market through prefilled syringes. In July 2023, Fresenius Kabi launched Ganirelix Acetate Injection, a generic fertility drug, in 250 mcg0.5 ml prefilled syringes as part of the company's expansion in women's health. Therefore, the increasing prevalence of diabetes and other disorders, along with surge in product launches, is expected to drive the growth of prefilled syringes market in the US.

North America Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)

North America Prefilled Syringe Market Segmentation

The North America prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.

Based on type, the North America prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger North America prefilled syringe market share in 2022.

Based on material, the North America prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger North America prefilled syringe share in 2022.

Based on designs, the North America prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger North America prefilled syringe share in 2022.

In terms of application, the North America prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest North America prefilled syringe share in 2022.

By distribution channel, the North America prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest North America prefilled syringe market share in 2022.

Based on country, the North America prefilled syringe market is categorized into the US, Canada, and Mexico. The US dominated the North America prefilled syringe market in 2022.

B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Gerresheimer AG, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the North America prefilled syringe market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Prefilled Syringe Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Chronic Disorders
- 4.1.2 Growing Adoption of Self-Injecting Parenteral Devices
4.2 Market Restraints
- 4.2.1 Increasing Product Recalls
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Ongoing Innovation in Prefilled Syringes
4.5 Impact Analysis

5. Prefilled Syringe Market - North America Market Analysis

5.1 North America Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030

6. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 North America Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Disposable Prefilled Syringes
- 6.3.1 Overview
- 6.3.2 Disposable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Reusable Prefilled Syringes
- 6.4.1 Overview
- 6.4.2 Reusable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Material

7.1 Overview
7.2 North America Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
7.3 Glass Prefilled Syringes
- 7.3.1 Overview
- 7.3.2 Glass Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Plastic Prefilled Syringes
- 7.4.1 Overview
- 7.4.2 Plastic Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Design

8.1 Overview
8.2 North America Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
8.3 Single Chamber
- 8.3.1 Overview
- 8.3.2 Single Chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Multi-chamber
- 8.4.1 Overview
- 8.4.2 Multi-chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Application

9.1 Overview
9.2 North America Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Cancer
- 9.3.1 Overview
- 9.3.2 Cancer: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
- 9.4.1 Overview
- 9.4.2 Diabetes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Autoimmune Diseases
- 9.5.1 Overview
- 9.5.2 Autoimmune Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Infectious Diseases
- 9.6.1 Overview
- 9.6.2 Infectious Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Distribution Channel

10.1 Overview
10.2 North America Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
10.3 Hospital Pharmacies
- 10.3.1 Overview
- 10.3.2 Hospital Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Retail Pharmacies
- 10.4.1 Overview
- 10.4.2 Retail Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Online Channels
- 10.5.1 Overview
- 10.5.2 Online Channels: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Prefilled Syringe Market - Country Analysis

11.1 North America Prefilled Syringes Market, Revenue and Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America Prefilled Syringes Market, by Country
  - 11.1.2.1 US
    - 11.1.2.1.1 US Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.1.2 US: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.1.3 US: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.2.1.4 US: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.2.1.5 US: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.2.1.6 US: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.2.2 Canada
    - 11.1.2.2.1 Overview
    - 11.1.2.2.2 Canada Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.2.3 Canada: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.2.4 Canada: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.2.2.5 Canada: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.2.2.6 Canada: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.2.2.7 Canada: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.2.3 Mexico
    - 11.1.2.3.1 Overview
    - 11.1.2.3.2 Mexico Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.3.3 Mexico: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.3.4 Mexico: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.2.3.5 Mexico: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.2.3.6 Mexico: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.2.3.7 Mexico: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 Organic Developments
- 12.2.1 Overview
12.3 Inorganic Developments
- 12.3.1 Overview

13. Company Profiles

13.1 B Braun SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Shandong Weigao Group Medical Polymer Co Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Gerresheimer AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Schott AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Nipro Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Becton Dickinson and Co
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Baxter International Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Terumo Corp
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Ypsomed Holding AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Prefilled Syringe Market Segmentation
Table 2. US Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. US Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Prefilled Syringe Market

List Of Figures

Figure 1. North America Prefilled Syringe Market Segmentation, By Country
Figure 2. North America Prefilled Syringe Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Disposable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Reusable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. North America Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
Figure 9. Glass Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Plastic Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
Figure 12. Single Chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Multi-chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. North America Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cancer: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Autoimmune Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 21. Hospital Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Online Channels: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: Prefilled Syringes Market, by Key Country - Revenue (2022) (US$ Million)
Figure 25. North America Prefilled Syringes Market, By Key Countries, 2022 and 2030 (%)
Figure 26. US Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Canada Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Mexico Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)